Arctic Therapeutics Gets EMA Nod for AT-001 Alzheimer Study
November 3, 2025
Arctic Therapeutics, a clinical-stage biopharmaceutical company based in Iceland, has announced regulatory clearance from the European Medicines Agency to begin a Phase IIa clinical trial